Cargando…
Pharmacoinformatic study of inhibitory potentials of selected flavonoids against papain-like protease and 3-chymotrypsin-like protease of SARS-CoV-2
BACKGROUND: Inhibition of papain-like protease (PLpro) and 3-chymotrypsin-like protease (3CLpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is projected to terminate its replication. Hence, these proteases represent viable therapeutic targets. METHODS: Sixty-one flavonoids with...
Autores principales: | Tijjani, Habibu, Adegunloye, Adegbenro P., Uba, Auwalu, Adebayo, Joseph O., Gyebi, Gideon A., Ibrahim, Ibrahim M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452863/ http://dx.doi.org/10.1186/s40816-022-00347-y |
Ejemplares similares
-
Structure-based virtual screening suggests inhibitors of 3-Chymotrypsin-Like Protease of SARS-CoV-2 from Vernonia amygdalina and Occinum gratissimum
por: Gyebi, Gideon A., et al.
Publicado: (2021) -
QSAR modeling and pharmacoinformatics of SARS coronavirus 3C-like protease inhibitors
por: Ishola, Ahmed Adebayo, et al.
Publicado: (2021) -
Identification of potent food constituents as SARS-CoV-2 papain-like protease modulators through advanced pharmacoinformatics approaches
por: Bhowmick, Shovonlal, et al.
Publicado: (2022) -
Loss of chymotrypsin-like protease (CTRL) alters intrapancreatic protease activation but not pancreatitis severity in mice
por: Mosztbacher, Dóra, et al.
Publicado: (2020) -
SARS-CoV-2 host cell entry: an in silico investigation of potential inhibitory roles of terpenoids
por: Gyebi, Gideon A., et al.
Publicado: (2021)